Clinical trials show progress in migraine frequency, skin cancer prevention
-
2:12
Schlesinger’s Saturday Showcase (10/25)...Busy pre-Halloween...
-
3:10
Last weekend in October gives us fairly quiet weather for all...
-
1:28
First round of playoffs: High school football highlights 🏈
-
2:24
‘I wouldn’t be able to live’: Milwaukee SNAP recipient...
-
1:52
Pewaukee’s TJ Watt says he’s ready to face the Packers
-
2:05
Baby girl surrendered in Racine’s Safe Haven Baby Box placed...
-
2:14
Committee advances proposal to add uniformed MCTS security at...
-
1:57
Horicon man forced to start over after losing home to arson in...
-
1:41
Kohler launches a new tool to understand your stool; meet Dekoda
-
2:07
’I want him to get the maximum sentence’: Family speaks out...
-
2:55
Trump administration denies state’s request for public assistance...
-
1:15
Bars and Recreation takes aim at fun with new Slingshot Bar
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.